Skip to main content
SpringerLink
Log in

Sertraline: the first SSRI to be approved for the specific treatment of post-traumatic stress disorder

  • New drugs and disease management
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Hidalgo RB, Davidson JRT. Posttraumatic stress disorder: epidemiology and health-related considerations. J Clin Psychiatry 2000; 61 Suppl.7: 5–13

    PubMed  Google Scholar 

  2. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington DC, American Psychiatric Association, 1994

    Google Scholar 

  3. Comer AM, Figgitt DP. Sertraline. A review of its therapeutic use in post-traumatic stress disorder. CNS Drugs 2000; 14 (5): 391–407

    Article  CAS  Google Scholar 

  4. Kessler RC, Sonnega A, Bromet E, et al. Posttraumatic stress disorder in the National Comorbidity Survey. Arch Gen Psychiatry 1995: 52: 1048–60

    Article  PubMed  CAS  Google Scholar 

  5. Expert Consensus Panels for PTSD. Treatment of posttraumatic stress disorder. J Clin Psychiatry 1999; 60 Suppl. 16: 1–76

    Google Scholar 

  6. Brady K, Pearlstein T, Asnis GM, et al. Efficacy and safety of sertraline treatment of posttraumatic stress disorder: a randomized controlled trial. J Am Med Assoc 2000; 283: 1837–44

    Article  CAS  Google Scholar 

  7. Davidson JR, Londborg PD, Pearlstein T, et al. Double-blind comparison of sertraline and placebo in patients with posttraumatic stress disorder [poster]. 36th Annual Meeting of the American College of Neuropsychopharmacology; 1997 Dec 8–12; Kamuela, Hawaii

    Google Scholar 

  8. Smith D. Sertraline for PTSD: NDA 19-839, statistical review. Slides from a meeting of the FDA Psycopharmacologic Drugs Advisory Committee 1999 Oct 8. Available from: URL: http://www.fda.gov/ohrms/dockets/ac/99/slides/3556sl.htm [Accessed 2000 Jul 5]

  9. Davidson JRT, Londborg PD, Pearlstein TB, et al. Double-blind, randomised, 28-week continuation study of sertraline and placebo in PTSD [abstract no. NR722]. American Psychiatric Association Annual Meeting: New Research Program & Abstracts; 2000 May 13–18; Chicago, 252–3

    Google Scholar 

  10. Londborg PD, Patterson W, Hegel M, et al. Results of a 24-week extension study of sertraline in PTSD [abstract no. NR237]. American Psychiatric Association Annual Meeting: New Research Program & Abstracts; 2000 May 13–18; Chicago, 120

    Google Scholar 

  11. Brady K, Farfel G. Effects of sertraline and placebo in women with PTSD [abstract no. PO-02-7]. World Psychiatric Association: XI World Congress of Psychiatry Abstracts Vol II; 1999 Aug 6–11; Hamburg, 90

  12. Friedman MJ, Mannar CR, Farfel GM. Effects of sertraline and placebo in men with PTSD [abstract no. NR238]. American Psychiatric Association Annual Meeting: New Research Program & Abstracts; 2000 May 13–18, Chicago, 120

    Google Scholar 

  13. Amital D, Zohar J, Kotier M, et al. A placebo-controlled pilot study of sertraline in PTSD [abstract no. NR331 + poster]. American Psychiatric Association Annual Meeting: New Research Program and Abstracts; 1999 May 15–20; Washington, DC, 156–7

    Google Scholar 

  14. Rothbaum B, Farfel G. Two multicenter trials evaluating sertraline and placebo for the treatment of PTSD [abstract no. NR310 and poster]. American Psychiatric Association Annual Meeting: New Research Program and Abstracts; 1999 May 15–20; Washington, DC, 151

    Google Scholar 

  15. Pfizer Inc. Zoloft®(sertraline hydrochloride) U.S. prescribing information. New York, NY, Pfizer Inc, 1999 Dec

  16. Edwards JG, Anderson I. Systematic review and guide to selection of SSRIs. Drugs 1999; 57: 507–33.

    Article  PubMed  CAS  Google Scholar 

  17. FDA clears Zoloft for post-trauma. Scrip 1999 Dec 10; 2497: 18

  18. Mackay FJ, Dunn NR, Wilton LV, et al. A comparison of fluvoxamine, fluoxetine, sertraline and paroxetine examined by observational cohort studies. Pharmacoepidemiol Drug Saf 1997; 6: 235–46

    Article  PubMed  CAS  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sertraline: the first SSRI to be approved for the specific treatment of post-traumatic stress disorder. Drugs Ther. Perspect 17, 1–5 (2001). https://doi.org/10.2165/00042310-200117160-00001

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00042310-200117160-00001

Keywords

Search

Navigation